-+ 0.00%
-+ 0.00%
-+ 0.00%

Market News: India's ZYDUS Life Sciences launches India's first once-daily nebulized long-term anticholinergic drug REVAHAL to treat chronic obstructive pulmonary disease.

Zhitongcaijing·08/10/2026 09:57:04
Listen to the news
Market News: India's ZYDUS Life Sciences launches India's first once-daily nebulized long-term anticholinergic drug REVAHAL to treat chronic obstructive pulmonary disease.